Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

ASTRO issues new guidance for pancreatic cancer

The American Society for Radiation Oncology (ASTRO) has updated its recommendations for using radiation therapy to treat patients with diagnosed pancreatic cancer.

Thumbnail

French startup Robocath raises $5.5M for CV robotics platform

French medtech startup Robocath has raised 5 million euros—the equivalent of $5.5 million in U.S. currency—in support of its cardiovascular robotics system, the company announced this month.

Thumbnail

Cancer replaces CVD as no. 1 killer in high-income countries

Researchers have uncovered evidence of a global “epidemiological transition” that’s seeing cancer overtake cardiovascular disease as the biggest killer in developed countries, Reuters reports.

Thumbnail

Productivity up, compensation down for diagnostic radiology in 2018

A new survey from AMGA found that physician compensation increased in 2018, but diagnostic radiologists didn’t experience that same bump.

Thumbnail

FDA fast-tracks dapagliflozin for treatment of CKD

The U.S. FDA this month granted Fast Track designation to AstraZeneca for the development of Farxiga, or dapagliflozin. 

Thumbnail

Wearables market to hit $54B in 2023

The wearable technology market reached $23 billion in 2018 and is projected to more than double to $54 billion by 2023, according to a new report from GlobalData.

Thumbnail

Productivity fell flat, but cardiology compensation increased in 2018

Cardiology compensation jumped 4.4% while productivity remained relatively stagnant between 2017 and 2018, AMGA reported in its 32nd annual Medical Group Compensation and Productivity Survey.

Thumbnail

Department of Energy reaches deal with 4th US company to fund Mo-99 production

The Department of Energy’s National Nuclear Security Administration (NNSA) has issued a cooperative agreement with a fourth U.S. company for the production of molybdenum-99 (Mo-99) without highly enriched uranium.